Vioxx Settlement Down, Merck Has Three More Government Probes Pending
Executive Summary
Sales rep call notes on Vioxx off-label promotion were a key part of the government’s criminal case against Merck; $950 million settlement includes a new corporate integrity agreement that requires monitoring of call notes.
You may also be interested in...
The Era Of Billion Dollar Pharma Settlements
Abbott Laboratories is the third pharmaceutical company to reach a settlement with the Department of Justice in excess of $1 billion. A look at the deals struck since Eli Lilly began the billion dollar club in 2009 shows the activities the government is investigating and the level of liability that companies face.
Merck’s Morass Of Marketing Probes: DoJ Seeks Data On Three More Drugs
Department of Justice has requested data on AzaSite, which Merck gained in its acquisition of Inspire Pharmaceuticals, Integrilin and Avelox.
GSK’s Deal With DoJ Is Fourth In Eight Years; Exec Liability Uncertain
GlaxoSmithKline PLC’s toughest negotiations this year have been with the federal government.